Implanting Hope for Lives

Advancing healthcare through scientific excellence, advanced manufacturing, and innovation — while contributing to the localization of pharmaceutical production in Saudi Arabia.

Our Story

Our journey is built on a strong purpose, a passion for excellence, and a commitment to creating a healthier tomorrow.

We continue to grow with innovation, integrity, and impact. 

Established in 2013
Patients served
0 M+
Registered products
0 +
Therapeutic areas
0 +
International markets
0 +

Our Journey

A Journey of Growth, Innovation, & Impact

From our foundation in 2013 to becoming a regional leader in pharmaceutical manufacturing, our journey is built on milestones that drive progress and improve lives.

The Beginning of a Vision

2013

The Beginning of a Vision

Sudair Pharma was established in February 2013, with a mission to strengthen local pharmaceutical manufacturing and improve patient access to essential therapies.

Building the Foundation

2016

Building the Foundation

The foundation stone was laid, and construction began on the first specialized anti-neoplastic and high-potency manufacturing facility.

Technology Transfer Begins

2017

Technology Transfer Begins

First anti-neoplastic technology transfer partnership secured, and anti-neoplastic manufacturing plant completed.

From Vision to Market

2018

From Vision to Market

First portfolio of 11 products registered into SFDA, with the first anti-neoplastic treatment launched.

Expanding Beyond Borders

2020

Expanding Beyond Borders

Expanded our portfolio to 45 registered products, while entering Bahraini and UAE markets.

Diversification & Localization

2021

Diversification & Localisation

Reaching 61 registered products and the localisation of the first anti-neoplastic product, Lenalidomide, completed.

Broadening Therapeutic Reach

2022

Broadening Therapeutic Reach

SAP S/4HANA, state-of-the-art enterprise resource management system implemented across operations.

Localization at Scale

2023

Localisation at Scale

Introduced the first and only sterile high-potent line in the Kingdom and localised the manufacturing of more than 10 pharmaceutical products.

A Landmark Year of Impact

2024

A Landmark Year of Impact

Signed the Kingdom’s first pharmaceutical off-take agreement and launched a major expansion of the Sudair Manufacturing Complex, introduced new products across anti-neoplastic, diabetes, and respiratory therapeutic areas.

Shaping the Future of Biopharma

2025

Shaping the Future of Biopharma

Insulin Manufacturing Facility construction initiated and localising 13 products, reaching 35 in total.

Transforming Lives

2026

Transforming Lives

Stepped into the biosimilars market. Registered 16 new products, increasing the total registered portfolio to 128 products and reached 39 fully manufactured products at Sudair Pharma facilities.

Our Purpose

Mission & Vision

Guided by a clear purpose and a shared vision, we are committed to improving lives through quality, innovation, and integrity.

Our Vision

We improve lives by localising advanced therapies

Our Mission

Enhancing our community’s access to high-quality medicinal products through our professional team, while localising and developing cutting-edge manufacturing technologies.

Global Pharmaceutical Partners
Supporting Saudi Vision 2030
Building a Healthier Future for Saudi Arabia

Sudair Pharma supports Saudi Vision 2030 by expanding local pharmaceutical manufacturing, developing Saudi talent, and strengthening access to high-quality medicines. Through localisation and innovation, we contribute to a more resilient and sustainable healthcare sector.

Saudi Vision 2030

Therapeutic Areas

Advancing Health.Transforming Lives.

From anti-neoplastic and hematology to respiratory, neurology, cardiometabolic and rare disease therapies — manufactured and supplied to international quality standards.

Advancing
Health.
Transforming
Lives.

Our Regional Presence

From Saudi Arabia to the region and beyond, we are committed to delivering high-quality medicines and improving lives.
Latest News
14 November 2026 · Local Content & Government Partnerships

On World Diabetes Day, we celebrate another milestone in our journey toward insulin localization in Saudi Arabia.

29 October 2025 · Exhibition

Sudair Pharma was honored to welcome His Excellency the Minister of Health, Fahad Al-Jalajel, during its participation in the Global Health Exhibition 2025. The visit highlighted the Kingdom’s commitment to strengthening national pharmaceutical manufacturing and advancing a sustainable healthcare system. Several senior officials and leaders also visited the booth, underscoring Sudair Pharma’s growing impact in shaping the future of Saudi healthcare.

27 October 2025 · Exhibition

Sudair Pharma participated in the Global Health Exhibition 2025, showcasing advanced national pharmaceutical capabilities and highlighting the company’s contribution to strengthening Saudi Arabia’s healthcare ecosystem. The SPC booth attracted significant interest and served as a platform for strategic discussions and industry engagement.